(Q62105866)

English

Safety and Efficacy of APD356 in the Treatment of Obesity

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A 4-Week, Dose-ranging, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of APD356 in Obese Patients (English)

0 references

medical condition

obesity

0 references

sponsor

Arena Pharmaceuticals

0 references

country

United States of America

0 references

main subject

obesity

0 references

start time

December 2004

0 references

number of participants

400

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00104507

0 references

(Q62105866)

Safety and Efficacy of APD356 in the Treatment of Obesity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)